SEARCH

SEARCH BY CITATION

References

  • Amtage F, Neughebauer B, McIntosh JM, Freiman T, Zentner J, Feuerstein TJ et al. (2004). Characterization of nicotinic receptors inducing noradrenaline release and absence of nicotinic autoreceptors in human neocortex. Brain Res Bull 62: 413423.
  • Azam L, McIntosh JM (2006). Characterization of nicotinic acetylcholine receptors that modulate nicotine-evoked [3H]norepinephrine release from mouse hippocampal synaptosomes. Mol Pharmacol 70: 967976.
  • Barik J, Wonnacott S (2006). Indirect modulation by α7 nicotinic acetylcholine receptors of noradrenaline release in rat hippocampal slices: Interaction with glutamate and GABA systems and effects of nicotine withdrawal. Mol Pharmacol 69: 618628.
  • Boehm S, Huck S (1995). 2-Adrenoreceptor-mediated inhibition of acetylcholine-induced noradrenaline release from rat sympathetic neurons: an action at voltage-gated Ca2+ channels. Neuroscience 69: 221231.
  • Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, McIntosh JM (1996). A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 271: 75227528.
  • Champtiaux N, Gotti C, Cordero-Erausquin M, David DJ, Przybylski C, Lena C et al. (2003). Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. J Neurosci 23: 78207829.
  • Clarke PBS, Reuben M (1996). Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release. Br J Pharmacol 117: 595606.
  • David V, Besson M, Changeux J-P, Granon S, Cazala P (2006). Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. Neuropharmacol 50: 10301040.
  • Fischer H, Orr-Urtreger A, Role LW, Huck S (2005). Selective deletion of the α5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse. J Physiol 563: 119137.
  • Fu Y, Matta SG, James TA, Sharp BM (1998). Nicotine-induced norepinephrine release in the rat amygdala and hippocampus is mediated through brainstem nicotinic cholinergic receptors. J Pharmacol Exp Ther 284: 11881196.
  • Grady SR, Murphy KL, Cao J, Marks MJ, McIntosh JM, Collins AC (2002). Characterization of nicotinic agonist-induced [3H]dopamine release from synaptosomes prepared from four mouse brain regions. J Pharmacol Exp Ther 301: 651660.
  • Kaiser S, Wonnacott S (2000). α-Bungarotoxin-sensitive nicotinic receptors indirectly modulate [3H]dopamine release in rat striatal slices via glutamate release. Mol Pharmacol 58: 312318.
  • Kaiser SA, Soliakov L, Harvey SC, Luetje CW, Wonnacott S (1998). Differential inhibition by α-conotoxin-MII of the nicotinic stimulation of [3H]dopamine release from rat striatal synaptosomes and slices. J Neurochem 70: 10691076.
  • Kristufek D, Stocker E, Boehm S, Huck S (1999). Somatic and prejunctional nicotinic receptors in cultured rat sympathetic neurones show different agonist profiles. J Physiol 516: 739756.
  • Kulak JM, Nguyen TA, Olivera BM, McIntosh JM (1997). α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J Neurosci 17: 52635270.
  • Lena C, de Kerchove d'Exaerde A, Cordero-Erausquin M, Le Novere N, del Mar Arroyo-Jimenez M, Changeux J-P (1999). Diversity and distribution of nicotinic acetylcholine receptors in the locus ceruleus neurons. Proc Natl Acad Sci 96: 1212612131.
  • Leslie FM, Gallardo KA, Park MK (2002). Nicotinic acetylcholine receptor-mediated release of [3H]norepinephrine from developing and adult rat hippocampus: direct and indirect mechanisms. Neuropharmacol 42: 653661.
  • Luo S, Kulak JM, Cartier GE, Jacobsen RB, Yoshikami D, Olivera BM et al. (1998). α-Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J Neurosci 18: 85718579.
  • Mansvelder HD, De Rover M, McGehee DS, Brussaard AB (2003). Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. Eur J Pharmacol 480: 117123.
  • Mansvelder HD, McGehee DS (2000). Long-term potentiation of excitatory inputs to brain reward areas by nicotine. Neuron 27: 349357.
  • Marks MJ, Bullock AE, Collins AC (1995). Sodium channel blockers partially inhibit nicotine-stimulated 86Rb+ efflux from mouse brain synaptosomes. J Pharmacol Exp Ther 274: 833841.
  • Marks MJ, Farnham DA, Sharon RG, Collins AC (1993). Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J Pharmacol Exp Ther 264: 542552.
  • Marks MJ, Stitzel JA, Grady SR, Picciotto MR, Changeux J-P, Collins AC (2000). Nicotinic-agonist stimulated 86Rb+ efflux and [3H]epibatidine binding of mice differing in β2 genotype. Neuropharmacol 39: 26322645.
  • Marshall D, Soliakov L, Redfern P, Wonnacott S (1996). Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum. Neuropharmacol 35: 15311536.
  • Mitchell SN (1993). Role of locus coeruleus in the noradrenergic response to a systemic administration of nicotine. Neuropharmacol 32: 937949.
  • Picciotto M, Caldarone BJ, Brunzell DH, Zachariou V, Stevens TR, King SL (2001). Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications. Pharm Ther 92: 89108.
  • Picciotto MR, Corrigall WA (2002). Neuronal systems underlying behaviors related to nicotine addiction: Neuronal circuits and molecular genetics. J Neurosci 22: 33383341.
  • Picciotto MR, Zoli M, Lena C, Bessis A, Lallemand Y, Le Novere N et al. (1995). Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374: 6567.
  • Role LW, Berg DK (1996). Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16: 10771085.
  • Sacaan AI, Dunlop JL, Lloyd GK (1995). Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J Pharmacol Exp Ther 274: 224230.
  • Sacaan AI, Menzaghi F, Dunlop JL, Correa LD, Whelan KT, Lloyd GK (1996). Epibatidine: a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: in vitro and in vivo evidence in rats. J Pharmacol Exp Ther 276: 509515.
  • Salas R, Orr-Urtreger A, Broide RS, Beaudet A, Paylor R, De Biasi M (2003). The nicotinic acetylcholine receptor subunit α5 mediates short-term effects of nicotine in vivo. Mol Pharmacol 63: 10591066.
  • Salminen O, Murphy KL, McIntosh JM, Drago J, Marks MJ, Collins AC et al. (2004). Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Mol Pharmacol 65: 15261535.
  • Sershen H, Balla A, Lajtha A, Vizi ES (1997). Characterization of nicotinic receptors involved in the release of noradrenaline from the hippocampus. Neuroscience 77: 121130.
  • Soliakov L, Gallagher T, Wonnacott S (1995). Anatoxine-a-evoked [3H]dopamine release from rat striatal synaptosomes. Neuropharmacol 34: 15351541.
  • Valenta B, Drobny H, Singer EA (1988). Presynaptic autoinhibition of central noradrenaline release in vitro: operational characteristics and effects of drugs acting at alpha-2 adrenoceptors in the presence of uptake inhibition. J Pharmacol Exp Ther 245: 944949.
  • Whiteaker P, Marks MJ, Grady SR, Lu Y, Picciotto MR, Changeux J-P et al. (2000). Pharmacological and null mutation approaches reveal nicotinic receptor diversity. Eur J Pharmacol 393: 123135.
  • Wonnacott S (1997). Presynaptic nicotinic ACh receptors. Trends Neurosci 20: 9298.
  • Wonnacott S, Kaiser S, Mogg A, Soliakov L, Jones IW (2000). Presynaptic nicotinic receptors modulating dopamine release in the rat striatum. Eur J Pharmacol 393: 5158.
  • Zhou F-M, Liang Y, Dani JA (2001). Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat Neurosci 4: 12241229.